09 July 2009
ohnson & Johnson (J&J, NJ, USA) has agreed to pay $1 billion (719 million euro) to acquire the assets and rights of the Alzheimer’s immunotherapy programme (AIP) of the biopharmaceutical company Elan (Ireland), to form a new company with Elan based on the AIP programme, and gain an 18.4% stake in Elan.
 |
09 July 2009
The US Pharmacopeia is revising its monographs for four pharmaceutical excipients: propylene glycol, sorbitol solution, sorbitol sorbitan solution, and noncrystalllizing sorbitol solution.
|
09 July 2009
The US National Institutes of Health (NIH) have issued on 7 July final guidelines for human stem-cell research that widen the door to the cell lines that can be used if they meet certain ethical requirements.
|
08 July 2009
Only two weeks after being granted a European patent covering the targeted PEGylation of proteins, PolyTherics has been granted a patent for the same technology — TheraPEG — in the US.
|
03 July 2009
The Committee for Medicinal Products for Human Use (CHMP) of the EMEA has recommended that the EC grants a marketing authorization for Belgium based-UCB's Cimzia, in combination with methotrexate, for the treatment of rheumatoid arthritis (RA).
|
03 July 2009
Although all Member States are in favouring of tightening pharmacovigilance rules, which element of the 'pharma package' is causing dispute?
|
03 July 2009
The UK's Medicines and Healthcare Regulatory Agency (MHRA) has published the outcome of a consultation on measures to strengthen the country's medicines supply chain.
|
03 July 2009
Could artificial organs help replace animals experiments? Researchers at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB (Germany) believe so; they have developed an artificial liver that they believe will offer greater security for pharma companies and shorten the path to new drugs.
|
03 July 2009
The Federal Trade Commission (FTC) last week issued an interim report that examined the effects of authorized generics on competition in the prescription drug market.
|
| 
